250 related articles for article (PubMed ID: 30348055)
21. Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Allison RS; Chaplin JM; Gregor RT; Lea R; Tan ST
J Surg Oncol; 2008 Aug; 98(2):101-5. PubMed ID: 18523982
[TBL] [Abstract][Full Text] [Related]
22. Age is not a predictor of prognosis in metastatic cutaneous squamous cell carcinoma of the head and neck.
Smith JA; Virk S; Palme CE; Low TH; Ch'ng S; Gupta R; Gao K; Clark J
ANZ J Surg; 2018 Apr; 88(4):E273-E277. PubMed ID: 29611361
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic and Prognostic Value of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: a systematic review and meta-analysis.
Wu XL; Tu Q; Faure G; Gallet P; Kohler C; Bittencourt Mde C
Sci Rep; 2016 Feb; 6():20210. PubMed ID: 26831813
[TBL] [Abstract][Full Text] [Related]
24. Identifying risk factors for the prognosis of head and neck cutaneous squamous cell carcinoma: A systematic review and meta-analysis.
Zeng S; Fu L; Zhou P; Ling H
PLoS One; 2020; 15(9):e0239586. PubMed ID: 32991600
[TBL] [Abstract][Full Text] [Related]
25. [Parotid gland as the main site of metastasis of the cutaneous squamous cell carcinoma of the head].
Teymoortash A
Laryngorhinootologie; 2007 Oct; 86(10):699-704. PubMed ID: 17879900
[TBL] [Abstract][Full Text] [Related]
26. Node-positive cutaneous squamous cell carcinoma of the head and neck: Survival, high-risk features, and adjuvant chemoradiotherapy outcomes.
Amoils M; Lee CS; Sunwoo J; Aasi SZ; Hara W; Kim J; Sirjani D; Colevas AD; Chang AL; Divi V
Head Neck; 2017 May; 39(5):881-885. PubMed ID: 28252823
[TBL] [Abstract][Full Text] [Related]
27. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
[TBL] [Abstract][Full Text] [Related]
28. Impact of Type 2 Diabetes Mellitus on Survival in Head and Neck Squamous Cell Carcinoma.
Foreman A; Lee DJ; McMullen C; de Almeida J; Muhanna N; Gama RR; Giuliani M; Liu G; Bratman SV; Huang SH; O'Sullivan B; Song Y; Xu W; Goldstein DP
Otolaryngol Head Neck Surg; 2017 Oct; 157(4):657-663. PubMed ID: 28849730
[TBL] [Abstract][Full Text] [Related]
29. Perineural invasion as a prognostic factor in head and neck squamous cell carcinoma: a systematic review and meta-analysis.
Zhu J; Zhou R; Wang Y; Yu M
Acta Otolaryngol; 2019 Nov; 139(11):1038-1043. PubMed ID: 31464544
[No Abstract] [Full Text] [Related]
30. Clinical perineural invasion of the trigeminal and facial nerves in cutaneous head and neck squamous cell carcinoma: Outcomes and prognostic implications of multimodality and salvage treatment.
Erkan S; Savundra JM; Wood B; Acharya AN; Rajan GP
Head Neck; 2017 Jul; 39(7):1280-1286. PubMed ID: 28474414
[TBL] [Abstract][Full Text] [Related]
31. Cancer of the head and neck region in solid organ transplant recipients.
Rabinovics N; Mizrachi A; Hadar T; Ad-El D; Feinmesser R; Guttman D; Shpitzer T; Bachar G
Head Neck; 2014 Feb; 36(2):181-6. PubMed ID: 23554129
[TBL] [Abstract][Full Text] [Related]
32. Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival.
Oddone N; Morgan GJ; Palme CE; Perera L; Shannon J; Wong E; Gebski V; Veness MJ
Cancer; 2009 May; 115(9):1883-91. PubMed ID: 19224549
[TBL] [Abstract][Full Text] [Related]
33. mTOR pathway protein immunoexpression as a prognostic factor for survival in head and neck cancer patients: a systematic review and meta-analysis.
Marques AE; Elias ST; Porporatti AL; Castilho RM; Squarize CH; De Luca Canto G; Guerra EN
J Oral Pathol Med; 2016 May; 45(5):319-28. PubMed ID: 26661562
[TBL] [Abstract][Full Text] [Related]
34. Outcomes after surgery and postoperative radiotherapy for perineural spread of head and neck cutaneous squamous cell carcinoma.
Warren TA; Panizza B; Porceddu SV; Gandhi M; Patel P; Wood M; Nagle CM; Redmond M
Head Neck; 2016 Jun; 38(6):824-31. PubMed ID: 25546817
[TBL] [Abstract][Full Text] [Related]
35. Outcome of patients treated surgically for lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
Givi B; Andersen PE; Diggs BS; Wax MK; Gross ND
Head Neck; 2011 Jul; 33(7):999-1004. PubMed ID: 21284049
[TBL] [Abstract][Full Text] [Related]
36. Multivariate analysis of potential risk factors for lymph node metastasis in patients with cutaneous squamous cell carcinoma of the head and neck.
Haisma MS; Plaat BEC; Bijl HP; Roodenburg JLN; Diercks GFH; Romeijn TR; Terra JB
J Am Acad Dermatol; 2016 Oct; 75(4):722-730. PubMed ID: 27473455
[TBL] [Abstract][Full Text] [Related]
37. Case-Control Study of Tumor Stage-Dependent Outcomes for Cutaneous Squamous Cell Carcinoma in Immunosuppressed and Immunocompetent Patients.
Gonzalez JL; Cunningham K; Silverman R; Madan E; Nguyen BM
Dermatol Surg; 2019 Dec; 45(12):1467-1476. PubMed ID: 30964787
[TBL] [Abstract][Full Text] [Related]
38. Clinical implications of hypoxia biomarker expression in head and neck squamous cell carcinoma: a systematic review.
Swartz JE; Pothen AJ; Stegeman I; Willems SM; Grolman W
Cancer Med; 2015 Jul; 4(7):1101-16. PubMed ID: 25919147
[TBL] [Abstract][Full Text] [Related]
39. Resection of subsequent pulmonary metastases from treated head and neck squamous cell carcinoma: systematic review and meta-analysis.
Young ER; Diakos E; Khalid-Raja M; Mehanna H
Clin Otolaryngol; 2015 Jun; 40(3):208-18. PubMed ID: 25358605
[TBL] [Abstract][Full Text] [Related]
40. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.
Bhanu Prasad V; Mallick S; Upadhyay AD; Rath GK
Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():75-81. PubMed ID: 28012539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
